[EN] SUBSTITUTED PYRIDINONE-CONTAINING TRICYCLIC COMPOUNDS, AND METHODS USING SAME<br/>[FR] COMPOSÉS TRICYCLIQUES CONTENANT DE LA PYRIDINONE SUBSTITUÉE, ET PROCÉDÉS LES UTILISANT
申请人:ARBUTUS BIOPHARMA INC
公开号:WO2018085619A1
公开(公告)日:2018-05-11
The present invention includes substituted pyridinone-containing tricyclic compounds, and compositions comprising the same, that can be used to treat or prevent hepatitis B virus (HBV) infection in a patient. In certain embodiments, the compounds and compositions of the invention inhibit and/or reduce HBsAg secretion.
Substituted pyridinone-containing trycyclic compounds, and methods using same
申请人:ARBUTUS BIOPHARMA CORPORATION
公开号:US10821103B2
公开(公告)日:2020-11-03
The present invention includes substituted pyridinone-containing tricyclic compounds, and compositions comprising the same, that can be used to treat or prevent hepatitis B virus (HBV) infection in a patient. In certain embodiments, the compounds and compositions of the invention inhibit and/or reduce HBsAg secretion.
SUBSTITUTED PYRIDINONE-CONTAINING TRICYCLIC COMPOUNDS, AND METHODS USING SAME
申请人:Arbutus Biopharma Corporation
公开号:EP3534903A1
公开(公告)日:2019-09-11
SUBSTITUTED PYRIDINONE-CONTAINING TRYCYCLIC COMPOUNDS, AND METHODS USING SAME
申请人:ARBUTUS BIOPHARMA CORPORATION
公开号:US20190314347A1
公开(公告)日:2019-10-17
The present invention includes substituted pyridinone-containing tricyclic compounds, and compositions comprising the same, that can be used to treat or prevent hepatitis B virus (HBV) infection in a patient. In certain embodiments, the compounds and compositions of the invention inhibit and/or reduce HBsAg secretion.
Synthesis of Benzodioxepinone Analoguesvia a Novel Synthetic Route with Qualitative Olfactory Evaluation
作者:Britta Drevermann、Anthony R. Lingham、Helmut M. Hügel、Philip J. Marriott
DOI:10.1002/hlca.200790085
日期:2007.5
benzodioxepinone structure (Scheme 1, Table 3). In light of the difficulty experienced in applying patented literature to deriving the analogues 12–18, particularly those with electron-withdrawing substituents, an alternative synthetic scheme was implemented for the construction of all analogues in favorable yields (Scheme 4, Table 3). Formation of the hydroxy-protected dihalo alkylating agent 24via epoxide cleavage